Cadmium exposure induces renal fibrosis by inhibiting hsa_circ_0075684/miR-363-3p/KLF4 signaling pathway
Authors:
Open Access
- 13 February 2026
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
To date, no effective chelation therapy exists to remove cadmium (Cd) from the kidneys, a condition that increases the risk of cadmium-induced chronic kidney disease among humans. consequently, it is vital to prevent kidney damage due to cadmium exposure. However, it has been challenging to identify an early diagnostic marker of cadmium-induced kidney damage through mechanism studies. Interestingly, our previous study revealed that the expression of the microRNA miR-363-3p was upregulated in workers who had been diagnosed with chronic occupational cadmium toxicity. Thus, we aimed to investigate the role of miR-363-3p and its potential signaling pathway in cadmium-induced kidney damage. In this study, we identified a novel signaling pathway, hsa_circ_0075684/miR-363-3p/Krüppel-Like Factor 4 (KLF4), through a comprehensive bioinformatics analysis involving six databases. Next, we validated the role of the hsa_circ_0075684/miR-363-3p/KLF4 pathway in human renal tubular epithelial cell line (HK-2) treated with 0, 5, 10 and 15 µM cadmium chloride (CdCl2). Reverse transcription quantitative PCR (RT-qPCR) and western blot analyses showed that cadmium exposure induced renal fibrosis by regulating the expression of classic renal fibrosis biomarkers, including Fibronectin (Fn), E-cadherin (E-cad) and α-smooth muscle actin (α-SMA) through hsa_circ_0075684/miR-363-3p/KLF4 pathway inhibition. In a mice subchronic model (treated with 0, 5, 10 and 20 mg/kg CdCl2), Masson’s staining revealed obvious renal fibrosis in mice treated with 5, 10 and 20 mg/kg CdCl2 compared to the control group. The altered expression of hsa_circ_0075684/miR-363-3p/KLF4 pathway components and classic renal fibrosis biomarkers in model mice exposed to cadmium was consistent with that observed in HK-2 cells. In summary, we first report hsa_circ_0075684/miR-363-3p/KLF4 axis in cadmium nephrotoxicity, positioning it as a potential early diagnostic marker for cadmium-induced renal fibrosis.Keywords
Funding Information
- Key Scientific Research Project Fund of GDHOD (Z2022-13)
- Key Scientific Research Project Fund of GDHOD (Z2023-07)
- National Natural Science Foundation of China (No. 81972990)
This publication has 55 references indexed in Scilit:
- Alleviative effect of melatonin against the nephrotoxicity induced by cadmium exposure through regulating renal oxidative stress, inflammatory reaction, and fibrosis in a mouse modelEcotoxicology and Environmental Safety, 2023
- MiR-449a downregulation alleviates the progression of renal interstitial fibrosis by mediating the KLF4/MFN2 axisInternational Urology and Nephrology, 2023
- Estimation of health risks associated with dietary cadmium exposureArchives of Toxicology, 2023
- Renal damage induced by cadmium and its possible therapy by mitochondrial transplantationChemico-Biological Interactions, 2022
- MiR‐363‐3p promotes prostate cancer tumor progression by targeting Dickkopf 3Journal of Clinical Laboratory Analysis, 2022
- CircRNA circ-ITCH improves renal inflammation and fibrosis in streptozotocin-induced diabetic mice by regulating the miR-33a-5p/SIRT6 axisInflammation Research, 2021
- Low Level of Serum Cadmium in Relation to Blood Pressures Among Japanese General PopulationBiological Trace Element Research, 2021
- MicroRNA-363-3p Inhibits the Expression of Renal Fibrosis Markers in TGF-β1-Treated HK-2 Cells by Targeting TGF-β2Biochemical Genetics, 2021
- Expressions and related mechanisms of miR-212 and KLF4 in rats with acute kidney injuryMolecular and Cellular Biochemistry, 2021
- Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studiesArchives of Toxicology, 2003